At the crumbling Bell Pottinger, shock must still be setting in. Less than two years ago after the British PR firm agreed to a £100,000 per month contract with South Africa’s well-connected and widely despised Gupta business empire, the company is collapsing as its reputation for representing the worst of the worst catches up with it.
On behalf of the Guptas, Bell Pottinger engaged in a campaign to incite racial hatred. By weaving narratives of “white monopoly capital” and “economic emancipation,” it stoked still-raw divisions within South African society to launder its clients’ reputations. South Africa’s civil society was in no mood to reconcile once the truth of the nefarious campaign came to light. Instead, the dogged efforts of anticorruption campaigners in South Africa hit Bell Pottinger all the way back in London.
Acting on a complaint from South Africa’s opposition Democratic Alliance, the UK Public Relations and Communications Association ejected Bell Pottinger and brought the company to its knees. South African activists are now after international consultancy firms McKinsey and KPMG, which have made millions working for the Guptas. South African NGO Corruption Watch has gone straight to the US Department of Justice with complaints about McKinsey.
South African corruption watchdogs have reason to celebrate. For years, an institutionalized culture of graft has set in across South Africa, abetted by President Jacob Zuma and his family. Zuma is an “ultimate survivor.” Despite multiple attempts to oust him, 780+ charges of corruption and public indignation over his clan’s ties with the Guptas, Zuma remains in power. His children have not fallen far from the tree: it was his son Duduzane who coordinated with Bell Pottinger on behalf of the Guptas.
Now that culture of impunity may be showing cracks. In working with authorities in the UK and the US, South African civil society is showing it understands that the fight for transparency crosses borders. As Bell Pottinger, McKinsey and KPMG reap the rewards of their work, other firms will learn the rules of decency still apply south of the Sahara.
Unfortunately, not all Western firms are as sensitive to public criticism. Anticorruption fighters are notching long-overdue victories in “Guptagate,” but they may soon have to use their new international partnerships to take on one of the most ruthless industries on the planet: Big Tobacco.
In terms of global predations on Africans, tobacco might be the most nefarious. Major companies like British American Tobacco (BAT) have a disturbing strategy: if American and European consumers are turning their backs on smoking, the global tobacco industry can instead pitch its deadly products to a whole new class of consumers in “untapped” sub-Saharan Africa.
The industry’s plans are stunning in their callousness. For decades, BAT has seen developing African markets as a main driver of future profits. As a 2007 tobacco conference in South Africa, the company described the country’s “Black middle class” as – incredibly – “Black Diamonds.” Indeed, the marketing carried out by BAT and its competitors deliberately targets young people as a future population of nicotine addicts to exploit.
BAT has also cajoled African governments into toeing their line. In South Africa, though, Jacob Zuma’s friends and family haven’t needed cajoling. One of his other sons, Edward, served as a tobacco company executive at a firm allegedly involved in the same kind of tobacco smuggling BAT has been accused of. After leaving the company, Zuma found himself locked in a legal dispute with the South African Revenue Service (SARS) over unpaid tobacco taxes.
A deeper scandal shows Zuma government officials working hand-in-hand with tobacco interests. In 2014, SARS became the target of a discomfiting campaign by South African politicians trying to negotiate with the taxman on the industry’s behalf. According to South Africa’s Daily Maverick, members of SARS and even Deputy Minister Marius Fransman helped the tobacco industry solicit the government’s cooperation to fight “illicit trade” and drive out SARS officials investigating its tax bills. One of the key figures in the scandal, Cape Town “kingpin” Mark Lifman, even attended Zuma’s birthday.
Fortunately, some South Africans are fighting back. Big Tobacco’s worst enemy may be Pravin Gordhan, former Finance Minister and SARS chief. Gordhan has been the tip of the spear in investigating tobacco smuggling in South Africa. He encouraged “sin taxes” on products including tobacco and initiatives like plain packaging (encouraged by the World Health Organization). Of course, this also made Gordhan a central target. His former deputies at SARS were put on trial while Gordhan himself was fired by Zuma at the end of March.
The firing has to do with far more than tobacco, but Edward Zuma (he of the cigarette tax dispute) still holds a grudge. Last month, the younger Zuma heckled Gordhan during a speech and claimed he “sold the country to the white men in Stellenbosch.” Like his brother Duduzane, Edward is apparently fond of dabbling in racial encitement.
In forcing Gordhan out, Zuma defended a corrupt system of patronage at the cost of economic crisis. As the Maverick showed, Big Tobacco may be just as guilty of “state capture” as the Gupta companies. Will the young South Africans the industry is banking on take up the fight against it? As Bell Pottinger now knows, foreign companies should be careful before assuming they can operate with impunity.
African Union’s Inaction on Ethiopia Deplorable – Open Letter
A group of African intellectuals says in an open letter that it is appalled and dismayed by the steadily deteriorating situation in Ethiopia. The letter, signed by 58 people, says the African Union’s lack of effective engagement in the crisis is deplorable. The letter calls on regional bloc IGAD and the AU to “proactively take up their mandates with respect to providing mediation for the protagonists to this conflict”.
The letter also asks for “all possible political support” for the AU’s Special Envoy for the Horn of Africa, Olusegun Obasanjo, whose appointment was announced on August 26, 2021. A United Nations Security Council meeting on the same day welcomed the former Nigerian president’s appointment.
Earlier in August 2021, UN chief Antonio Guterres appealed for a ceasefire, unrestricted aid access and an Ethiopian-led political dialogue. He told the council these steps were essential to preserve Ethiopia’s unity and the stability of the region and to ease the humanitarian crisis. He said that he had been in close contact with Ethiopian Prime Minister Abiy Ahmed and had received a letter from the leader of the Tigray region in response to his appeal. “The UN is ready to work together with the African Union and other key partners to support such a dialogue,” he said.
August 26, 2021 was only the second time during the conflict that the council held a public meeting to discuss the situation. Britain, Estonia, France, Ireland, Norway and the United States requested the session.
Fighting between the national government and the Tigray People’s Liberation Front broke out in November 2020, leaving millions facing emergency or crisis levels of food insecurity, according to the United Nations. Both sides have been accused of atrocities.
Africa: The G20 Must Recommit to Covax
It is one year since the international community gave its backing to the COVID-19 Vaccine Global Access (COVAX) facility to lead a worldwide effort to end the acute phase of the pandemic. The initiative aimed to ensure that every country, and not just those with sufficient money or resources, could access life-saving vaccines once they became available. As G20 health ministers prepare to meet in Rome on September 5-6, they are in a position to ensure that COVAX fulfills its mission.
A year ago, no one knew when or even if it might be possible to develop a safe and effective vaccine against COVID-19, let alone the 20 that are available today. But since making its first international deliveries in February, COVAX a partnership established by the Coalition for Epidemic Preparedness Innovations, the World Health Organization, UNICEF, and Gavi, the Vaccine Alliance has delivered more than 235 million vaccine doses to 139 countries, and expects to deliver another billion doses in the fourth quarter. Only China, India, and the United States have delivered more. This start to the largest and most complex vaccine rollout in history has given hope to millions of people and laid solid foundations for how we respond to future pandemics.
Yet, so much more could, and should, have been achieved by now. It is unacceptable that only 1.8% of people in low-income countries have received their first dose of a COVID-19 vaccine, compared to 82% in high- and upper-middle-income countries. This shocking inequality is as economically senseless as it is destructive to human life, with the latest estimate of the cost of the slow rollout amounting to $2.3 trillion.
The world was woefully unprepared for a pandemic, and this is reflected in the challenges COVAX has faced. By the time initial funding arrived, wealthy countries had already locked up early vaccine supplies. Export bans affecting key suppliers, and difficulties experienced by many manufacturers in scaling up production to the required level, also undermined COVAX’s ability to access doses early.
Given increasing global vaccine inequity and the rise of new, more contagious coronavirus variants, we must put these challenges behind us. Thanks to the support of almost all G20 governments, alongside that of foundations and private businesses, COVAX has now raised nearly $10 billion and secured more than 600 million donated doses. All the preparations are in place for the most comprehensive vaccination effort that the world has seen.
Based on the committed orders COVAX has placed with vaccine manufacturers and the additional donations, hundreds of millions of new doses should now be available each month. We need to make sure they reach poorer countries and get into people’s arms. To avoid further delays, and for the facility to succeed, we need support from G20 leaders in four key areas.
First, we need doses, and we need them now. The premise of COVAX was always that the facility should be able to negotiate and buy its own doses. With our early vaccine access compromised, donations have played a vital role in maintaining our ability to keep doses flowing to those most in need. Of the 600 million doses pledged to COVAX to date, 100 million have now been delivered. We need more, and soon, with longer shelf lives and greater certainty so that recipient countries have time to plan their rollout. This can be achieved without jeopardizing high-income countries’ national vaccination efforts.
We also need G20 leaders to support our call for transparency. COVAX has legally binding agreements with manufacturers for more than four billion doses, but has all too often faced delays in accessing them. Without greater clarity regarding firms’ order books, it is impossible to know whether these holdups are due to production challenges or preferential treatment for bilateral arrangements. Insisting that manufacturers are transparent about their order timelines can ensure a level playing field where no one particularly those living in developing countries gets bumped to the back of the vaccine queue because of another bilateral deal.
In addition to ensuring that manufacturers keep their commitment to COVAX, governments should make global vaccine access their highest priority. Countries with pending orders for doses that they currently do not need should allow COVAX to take their place in the queue so that we can get doses to needy countries now.
Finally, lower-income countries require continued financial and technical support for their COVID-19 vaccine rollouts. Strengthening national health systems will help these countries to ensure delivery of doses and mitigate the pandemic’s secondary effects, and will leave in place infrastructure critical to future global health security.
By recommitting to COVAX, G20 leaders will recommit to a multilateral solution that builds on the astounding scientific progress of the past year. Based on COVAX’s latest forthcoming supply forecast, when topped up with doses through bilateral deals, equitable COVID-19 vaccine access can protect up to 60% of the adult population in 91 lower-income countries. This would represent a huge step toward the WHO target of 70%, which is needed to suppress the coronavirus everywhere, and COVAX represents the best opportunity to achieve it.
Failure would mean more lives lost, broken health-care systems, even deadlier and more transmissible variants, and a pandemic with no end in sight. The G20 must not allow that to be an option.
More African Countries Register Russia’s Sputnik Vaccine
Africa Centres for Disease Control and Prevention (Africa CDC) is a specialized technical institution of the African Union (AU) that strengthens the capacity and capability of Africa’s public health institutions as well as partnerships to detect and respond quickly and effectively to disease threats and outbreaks, based on data-driven interventions and programmes.
During the outbreak of the coronavirus, the African Vaccine Acquisition Task Team (AVATT), was established by African Union, as a component in support of the Africa Vaccine Strategy and was endorsed by the AU Bureau of Heads of State and Government on 20th of August 2020.
Dr John Nkengasong, Director of the Africa Centers for Disease Control and Prevention (Africa CDC), has emphasized: “Africa has to team up with development partners to achieve its 60% continent-wide vaccination in the next two years. I think that is why we should as a collective of the continent, and of course, in partnership with the developed world make sure that Africa has a timely access to vaccines to meet our vaccination targets.”
An official media release in February 2021, the Africa Vaccine Acquisition Task Team from the African Union (AU) informed that Russia would supply and deliver 300 million Sputnik V vaccines to Africa. That step was intended to support African countries to attain their targeted immunization of 60% of the population by the year-end. That vaccine story disappeared, but instead what become so common is the speedy registration of Sputnik V on bilateral basis in various African countries.
According to the latest, Nigeria has become the 68th country in the world to approve the Russian vaccine. The use of the Sputnik V coronavirus vaccine has been approved in Nigeria, the Russian Direct Investment Fund (RDIF) said in an official statement.
“The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by the National Agency for Food and Drug Administration and Control of Nigeria (NAFDAC). Nigeria has become the 68th country in the world to approve the Russian vaccine. Total population of all countries, where Sputnik V is approved for use, now exceeds 3.7 billion people, which is nearly half of the global population,” the statement said.
“Nigeria is the most populous nation in Africa, and the approval of Sputnik V will provide for using one of the safest and most effective vaccines in the world. Sputnik V is based on a proven human adenoviral vectors platform and is successfully used in over 50 countries. Approval in Nigeria will make an important contribution to the country’s fight against the pandemic,” CEO of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said.
Besides Nigeria, other African countries have registered Russia’s Sputnik V vaccine. Reportedly, the vaccine has been registered in Algeria, Angola, Djibouti, Egypt, Gabon, Ghana, Guinea, Kenya, Morocco, Namibia, Tunisia, the Republic of Congo (DRC) and Zimbabwe.
Russia’s drive to share Sputnik V vaccine, of course, offers a chance to raise its image and strengthen alliances in Africa. Ministry of Foreign Affairs of the Russian Federation has made efforts promoting the vaccine using all its channels. But supply and delivery have largely lagged behind, the pledges have simply not been fulfilled. Russian authorities have oftentimes said that they would step up efforts for fruitful cooperation in combating coronavirus in Africa.
Promising more than can be delivered appears to be a universal problem with coronavirus vaccines, and it is a real risk for Russia as well, said Theresa Fallon, Director of the Brussels-based Centre for Russia Europe Asia Studies. “They have won the gold medal for creating this very effective vaccine,” she said. “But the problem is how are they going to implement production and delivery?”
Russian Direct Investment Fund (RDIF), with profit motivation, has attempted supplying the Russian vaccines through, Sheikh Ahmed Dalmook Al Maktoum, from the Monarch family and a third party in Dubai, United Arab Emirates, to a number of African countries. For instance, the Republic of Ghana reportedly signed US$64.6 million contract for Sputnik V vaccine from Russia through Sheikh Ahmed Dalmook Al Maktoum. It was double the price from the producer as reported in the media.
On the other hand, Russian President Vladimir Putin has noted, in a speech early September, that advanced countries that produce vaccines against the coronavirus do little to protect humanity from the pandemic.
“The benefits of vaccination are enjoyed mostly by advanced economies. The bulk of the vaccines is made there, and it is used to protect their own population. But very little is being done to protect humanity in the broad sense,” Putin said at the plenary session of the Eastern Economic Forum in Vladivostok, the Far East of Russia. “This is very bad for the producers, because all this boomerangs around the globe. For instance, in Africa the level of protection with vaccines is minimal, but contacts with the African countries continue. There is no getting away from this. This infection will return again and again.”
According to an official release obtained late February, the Sputnik V vaccine the following advantages:
• Efficacy of Sputnik V is 91.6% as confirmed by the data published in the Lancet, one of the world’s oldest and most respected medical journals; It is one of only three vaccines in the world with efficacy of over 90%; Sputnik V provides full protection against severe cases of COVID-19.
• The Sputnik V vaccine is based on a proven and well-studied platform of human adenoviral vectors, which cause the common cold and have been around for thousands of years.
• Sputnik V uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots.
• The safety, efficacy and lack of negative long-term effects of adenoviral vaccines have been proven by more than 250 clinical studies over two decades.
• The developers of the Sputnik V vaccine are working collaboratively with AstraZeneca on a joint clinical trial to improve the efficacy of AstraZeneca vaccine.
• There are no strong allergies caused by Sputnik V.
• The price of Sputnik V is less than $10 per shot, making it affordable around the world.
In February, peer-reviewed medical journal The Lancet published an analysis from Phase III clinical trial of the Russian vaccine, showing its 91.6-percent efficacy against symptomatic COVID-19. The Sputnik V vaccine was developed by the Gamaleya Research Institute of Epidemiology and Microbiology.
Sputnik V was registered in Russia on August 11, 2020 as the world’s first officially registered coronavirus vaccine. Russian vaccines have advantages as no deaths have been reported after vaccination with the Sputnik V, Alexander Gintsburg, Director of the Gamaleya Center, the vaccine developer, said and was reported by TASS News Agency. “As of today, no deaths after vaccination with Sputnik V have been registered,” he said.
Russian Direct Investment Fund (RDIF) is Russia’s sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management is based in Moscow.
In Africa, during first of September, the coronavirus-related death toll has topped 196,190, while more than 6.9 million recoveries have been reported. South Africa accounts for a majority of coronavirus cases and deaths across Africa – 2,777,659 and 82,261 respectively. The death toll in Tunisia climbed to 23,451, and 664,034 cases have been confirmed. Egypt recorded 16,736 deaths and 288,441 coronavirus cases.
In Sub-Saharan Africa, Ethiopia is ranked second to South Africa (308,134 cases and 4,675 deaths) and is followed by Kenya (235,863 cases and 4,726 deaths) and Nigeria (191,805 and 2,455). The total number of COVID-19 cases has reached almost 8 million in Africa, according to the World Health Organization’s (WHO) Regional Office for Africa.
Biden’s worrisome construct of security and self-defense in the first year of his term
US President Joe Biden’s foreign policy is failing so far. He can’t get the Iran nuclear diplomacy on track. The Afghanistan withdrawal...
Picking the perfect social media channel
No product or service can be purchased if nobody knows that it exists. This is the function of marketing, which...
Your brand needs to be on Twitter, here is why
Most of us are familiar with doing business physically through stores, but with the introduction of the internet, there are...
Instagram: Why It Is the Best Social Media Platform for Marketing
Were it not for social media platforms, most small business startups might not get out of the starting blocks. Traditional...
Multiple reports of alleged human rights violations in Tigray
UN human rights chief, Michelle Bachelet on Monday deplored “multiple and severe reports of alleged gross violations of human rights, humanitarian and...
Visit of Chinese Foreign Minister to Southeast Asia
Following the visit of Kamala Harris, the vice president of the USA to Vietnam and Singapore, the Chinese foreign minister...
Biden’s credibility restoration plan
Although damages of the United States’ withdrawal from Afghanistan cannot be easily undone, by taking a series of wise steps,...
Intelligence4 days ago
Russia, Turkey and UAE: The intelligence services organize and investigate
Defense3 days ago
HTS enters Turkey’s plot against the Kurds
South Asia3 days ago
The Taliban Dilemma and Thucydides Trap
Energy News4 days ago
Indonesia’s First Pumped Storage Hydropower Plant to Support Energy Transition
South Asia2 days ago
Afghanistan: Hazaras in danger of extinction
Economy3 days ago
Global Revolution in the Crypto World: Road to Legalization
South Asia3 days ago
Why the Taliban Had to Change
Russia4 days ago
Russian Authorities Going Forth and Back with Migration Policy